- The trend backdrop is active with a 12-week active streak.
- Volume is elevated versus the 13-week average, confirming attention.
NATHBIOGEN
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Nath Bio-Genes (India) Limited · Basic Materials · Agricultural Inputs
Latest close
157.7 INR
-0.9%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is -0.1% below the Trend Line and sits at 40.5% of its 52-week range. The latest completed week returned -0.9%, after a -4.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 57/100.
Setup score
43
out of 100
Latest Close
157.7 INR
7 Aug 2026
1W Return
-0.9%
latest completed week
4W Return
-4.3%
short-term follow-through
12W Return
-2.0%
quarterly tape
Trend Breadth
26.9%
14 of 52 weeks active
Volume Ratio
1.9x
vs 13-week average
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.9%
Latest completed week; four-week move -4.3%.
Indicator stack
56/0
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
57/100
6 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is -0.1% below the Trend Line and sits at 40.5% of its 52-week range. The latest completed week returned -0.9%, after a -4.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3612-week average 0.42
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.36Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.3% over four weeks, -2.0% over 12 weeks, and -7.7% over one year. The current trend has remained active for 12 consecutive weeks.
Performance by holding period
Active trend streak12 weeks
Active weeks in one year14
Trend breadth26.9%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.56Latest activity-pressure read.
Pressure change-492.3%Four-week change in activity pressure.
Leadership-1.14Latest relative-leadership reading.
RS change-129.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 88%
Model confidence 82%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength75/100Blend of value, momentum, and quality. Underlying universe rank 26; rank 1 is best.
Value95/100Relative valuation strength. Underlying universe rank 6; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum35/100Medium-term price momentum. Underlying universe rank 66; rank 1 is best.
Growth70/100Revenue and earnings growth. Underlying universe rank 31; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework73/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 9.2x Price divided by trailing earnings.
- Price / sales
- 0.7x Market value relative to trailing revenue.
- EV / EBITDA
- 6.1x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -4.3% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 54.7% Gross profit retained from each unit of revenue.
- Operating margin
- 8.9% Operating profit retained from revenue.
- Free-cash-flow margin
- -3.5% Free cash flow generated from revenue.
- Return on invested capital
- 4.0% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 22.0% Latest one-year revenue growth.
- EPS growth
- 7.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -261.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.3% Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 1.3% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 1.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment57/100
Weighted news tone is neutral across 6 relevant articles.
1 positive · 5 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-22.7%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+15.9%Week of 1 May.
Worst week-12.7%Week of 8 May.
Latest week-0.9%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks0
Modest losses12
Sharp losses4
Recent vol3.4%13-week weekly-return volatility.
Base vol5.0%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew4.4% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Agricultural Inputs
4-week rank37 / 47
Group average0.9%
Trend breadth19.1%
Trend19.1%active weekly trend signals
MD36.2%positive activity pressure
RS14.9%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape42/100
Trend, activity pressure, participation, and risk combine to a 42/100 tape read.
Indicator analysis71/100Latest 12-week confirmation: trend 12/12, activity pressure 8/12, relative leadership 11/12.
Activity pressure 0.36; No reversal markers Factors55/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Tiny Titans rank 39; Buyback Yield rank 46; Small Cap Core rank 6 SVQF73/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 423.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment57/100Weighted news tone is neutral across 6 relevant articles.
Nath Bio-Genes (India) Ltd. Revenue Breakdown – NSE:NATHBIOGEN Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 157.7 INR | -0.9% | 157.8 INR | 182.5 INR | -0.56 | -1.14 | 173.3K | On |
| 31 Jul 2026 | 159.2 INR | -1.2% | 157.6 INR | 182.9 INR | -0.44 | 0.39 | 137.0K | On |
| 24 Jul 2026 | 161.1 INR | 0.7% | 157.6 INR | 183.4 INR | -0.26 | 4.00 | 72.8K | On |
| 17 Jul 2026 | 160.0 INR | -2.9% | 157.5 INR | 183.7 INR | -0.05 | 0.72 | 55.4K | On |
| 10 Jul 2026 | 164.8 INR | -1.4% | 157.2 INR | 184.0 INR | 0.14 | 3.86 | 34.8K | On |
| 3 Jul 2026 | 167.1 INR | -0.8% | 156.8 INR | 184.2 INR | 0.26 | 4.38 | 4.3K | On |
| 26 Jun 2026 | 168.4 INR | 4.7% | 155.9 INR | 184.6 INR | 0.34 | 5.67 | 0 | On |
| 19 Jun 2026 | 160.8 INR | -3.4% | 155.5 INR | 184.6 INR | 0.50 | 0.79 | 154.0K | On |
| 12 Jun 2026 | 166.4 INR | -1.7% | 155.4 INR | 184.8 INR | 0.68 | 5.70 | 17.4K | On |
| 5 Jun 2026 | 169.3 INR | -3.3% | 155.5 INR | 184.9 INR | 0.79 | 8.43 | 20.9K | On |
| 29 May 2026 | 175.2 INR | 1.4% | 155.5 INR | 185.0 INR | 1.05 | 11.21 | 123.2K | On |
| 22 May 2026 | 172.8 INR | 7.4% | 155.5 INR | 184.9 INR | 1.28 | 8.90 | 210.4K | On |
| 15 May 2026 | 160.9 INR | -6.0% | 155.4 INR | 184.9 INR | 1.39 | 1.64 | 212.7K | Off |
| 8 May 2026 | 171.2 INR | -12.7% | 155.6 INR | 184.8 INR | 1.61 | 5.58 | 383.9K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.